[Form 4] Scansource Inc Insider Trading Activity

Rhea-AI Filing Summary

Insider purchase reported: Temple Elizabeth Orazem, a director of ScanSource, Inc. (SCSC), acquired 3,693 shares of the company's common stock on 09/01/2025 at no cash price reported, leaving her with 35,893 shares beneficially owned. The Form 4 shows the acquisition was a direct purchase and the filing was signed by an attorney-in-fact.

Insights

Financial Analyst

TL;DR: A director increased direct holdings by 3,693 shares, modestly raising insider ownership to 35,893 shares.

The transaction is a straightforward, non-derivative acquisition recorded on the Form 4. The purchase increases the director's direct stake, which can signal confidence but is small relative to typical company market caps. No price was reported on the form (listed as $0.00), and no derivative transactions or dispositions accompany this filing.

Corporate Governance Expert

TL;DR: Director's direct purchase is a routine insider transaction with limited immediate governance implications.

The form indicates compliance with Section 16 reporting by disclosing the acquisition and resulting beneficial ownership. There are no indications of option exercises, plan-related transactions, or changes to ownership structure beyond the incremental share increase. The filing was executed by an attorney-in-fact, which is a common administrative practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Temple Elizabeth Orazem

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SC 29615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		A		3,693	A	$0.00	35,893	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	J. Creighton Lynes, attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Temple Elizabeth Orazem acquire for SCSC?

She acquired 3,693 shares of ScanSource common stock as reported on the Form 4.

How many ScanSource (SCSC) shares does the director own after the transaction?

Following the reported acquisition, she beneficially owns 35,893 shares.

Was the Form 4 for SCSC a purchase or a sale?

The Form 4 reports an acquisition (A) of common stock, not a disposition.

Did the filing report any derivative transactions for SCSC?

No. The Form 4 shows only a non-derivative common stock acquisition; Table II for derivatives is empty.

Who signed the SCSC Form 4 filing?

The filing shows it was signed by an attorney-in-fact, J. Creighton Lynes.